Module 2: Stroke Risk Assessment

CHA₂DS₂-VASc stroke risk scoring for atrial fibrillation. Assess thromboembolic risk to guide anticoagulation decisions per the 2023 ACC/AHA/ACCP/HRS guideline.

1.Classification 2.Stroke Risk 3.Bleeding Risk 4.Anticoagulation 5.Rate Control 6.Rhythm Control 7.Ablation 8.LAA Closure 9.Lifestyle 10.AF + HF 11.Valvular 12.ACS/PCI 13.Special Pops

Calculate CHA₂DS₂-VASc stroke risk score per the 2023 ACC/AHA/ACCP/HRS AF Guideline (Section 6.1, Table 10).

Age*

years

Sex*

CHA₂DS₂-VASc Score — 2023 ACC/AHA/ACCP/HRS AF Guideline, Section 6.1, Table 10

Score 0 (male): Low risk, no OACScore 0-1 (female): Low risk, no OACScore 1 (male): Intermediate, consider OACScore 2 (female): Intermediate, consider OACScore ≥2 (male): High risk, OAC recommendedScore ≥3 (female): High risk, OAC recommended

Source: Joglar JA, et al. 2023 ACC/AHA/ACCP/HRS Guideline. Circulation. 2024;149:e1-e156.

IMPORTANT: This software is clinical decision support (CDS) intended for use by licensed healthcare professionals under Section 520(o)(1)(E) of the Federal Food, Drug, and Cosmetic Act. It is not intended as a medical device. All recommendations are derived from the 2023 ACC/AHA/ACCP/HRS Guideline for Diagnosis and Management of Atrial Fibrillation and must be independently verified by the treating clinician before any clinical action. AI-generated content (including extracted data and clinical notes) is produced by large language models and may contain errors, omissions, or hallucinations — clinician review is mandatory. Patient data entered into the calculator is processed entirely in the browser; AI features process data server-side under a signed HIPAA Business Associate Agreement with no data retention. AI-HEART Lab, its affiliates, and contributors assume no liability for clinical decisions made using this tool. By using this tool, you acknowledge these limitations and accept full responsibility for clinical decisions.